Table 4 Multivariate analysis of predictors of clinical outcomes of SARP

Ipsilateral lung

V₅ (%)

0.049

0.225

0.051–0.993

V₁₀ (%)

0.236

8.961

0.239–335.900

V₃₀ (%)

0.343

0.395

0.058–2.692

Contralateral lung

V₅ (%)

0.057

0.152

0.022–1.058

V₁₀ (%)

0.268

14.482

0.128–1642.168

V₃₀ (%)

0.904

1.153

0.115–11.549

Total lung

V₅ (%)

0.048

40.976

1.029–1632.127

V₁₀ (%)

0.209

0.003

0.000–25.700

V₃₀ (%)

0.286

9.601

0.151–610.532

Mean total lung dose (cGy)

0.121

0.986

0.969–1.004

Mean heart dose (cGy)

0.136

1.004

0.999–1.008

maximum spinal cord dose (cGy)

0.705

1.000

0.999–1.002